title: A randomized controlled trial of cognitive remediation and work therapy in the early phase of substance use disorder recovery for older veterans: Neurocognitive and substance use outcomes.
abstract: Cognitive remediation therapy (CRT) is reported to improve neurocognitive and substance use disorder (SUD) outcomes in residential treatments. This National Institute of Drug Abuse funded pilot study reports on CRT as an augmentation to outpatient treatment for SUD.
  
  
  
  Recovering outpatient veterans were randomized into CRT + Work Therapy (n = 24) or work therapy (n = 24) with treatment-as-usual. Blind assessments of neurocognition and substance use were performed at baseline, 3 months (end of treatment), and 6-month follow-up.
  
  
  
  Baseline assessments revealed high rates of cognitive impairment with 87.5% showing significant decline from premorbid IQ on at least 1 measure (median = 3/14 measures). Adherence to treatment was excellent. Follow-up rates were 95.7% at 3 months and 87.5% at 6 months. Mixed effects models of cognitive change over time revealed significant differences favoring CRT + Work Therapy on working memory (WM) and executive function indices. Global index of cognition showed a nonsignificant trend (effect size [ES] = .37) favoring CRT + Work Therapy. SUD outcomes were excellent for both conditions. CRT + Work Therapy had a mean of 97% days of abstinence at 3 months, 94% in the 30 days prior to 6-month follow-up, and 24/26 weeks of total abstinence; differences between conditions were not significant.
  
  
  
  CRT was well accepted by outpatient veterans with SUDs and led to significant improvements in WM and executive functions beyond that of normal cognitive recovery. No difference between conditions was found for SUD outcomes, perhaps because work therapy obscured the benefits of CRT. (PsycINFO Database Record
authors.affiliation: Department of Psychiatry, Yale University School of Medicine.
authors.forename: Morris D
authors.initials: MD
authors.lastname: Bell
authors.affiliation: Department of Psychiatry, Yale University School of Medicine.
authors.forename: Holly B
authors.initials: HB
authors.lastname: Laws
authors.affiliation: Department of Psychiatry, Yale University School of Medicine.
authors.forename: Ismene B
authors.initials: IB
authors.lastname: Petrakis
mesh_terms: D000328:Adult; D060825:Cognitive Dysfunction / Q000209:etiology / Q000534:rehabilitation*; D000072466:Cognitive Remediation / Q000379:methods*; D056344:Executive Function / Q000502:physiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008570:Memory, Short-Term / Q000502:physiology*; D008875:Middle Aged; D010865:Pilot Projects; D012050:Rehabilitation, Vocational / Q000379:methods*; D019966:Substance-Related Disorders / Q000150:complications / Q000534:rehabilitation*; D014728:Veterans